04:35 PM EDT, 08/08/2025 (MT Newswires) -- Bicycle Therapeutics ( BCYC ) filed a registration statement late Friday for the sale of $500 million of securities.

The securities cover ordinary stock, American depositary shares representing ordinary shares, preferred stock, debt securities, warrants, rights and units, according to the filing.

The company said it plans to use the net proceeds for general corporate purposes and may also use a portion to invest in or acquire businesses or technologies.